PYRIMETHAMINE

PYRIMETHAMINE was reported 1270 times

PYRIMETHAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL MALARIA 3 0.6000
1 TRANSPLANT ABSCESS 6 0.1304
2 CONGENITAL TOXOPLASMOSIS 7 0.1296
3 ENCEPHALITIS PROTOZOAL 6 0.1071
4 JOINT VIBRATION 2 0.0952
5 HEPATIC AMOEBIASIS 6 0.0896
6 ENCEPHALITIS HAEMORRHAGIC 1 0.0769
7 CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY RESPONSE 3 0.0714
8 LABYRINTHINE FISTULA 1 0.0526
9 CEREBRAL TOXOPLASMOSIS 47 0.0503
10 DISSEMINATED TOXOPLASMOSIS 5 0.0417
11 PULMONARY VENOUS THROMBOSIS 6 0.0400
12 SCHISTOSOMIASIS 3 0.0390
13 URINARY TRACT INFLAMMATION 14 0.0389
14 ACANTHAMOEBA INFECTION 7 0.0372
15 WOUND DECOMPOSITION 6 0.0361
16 END STAGE AIDS 1 0.0357
17 INFECTION PROTOZOAL 2 0.0351
18 BALAMUTHIA INFECTION 1 0.0345
19 CENTRAL PAIN SYNDROME 9 0.0340
20 MELANOCYTIC HYPERPLASIA 1 0.0312
21 CONDUCTIVE DEAFNESS 10 0.0312
22 TOXOPLASMOSIS 32 0.0296
23 KERATOUVEITIS 1 0.0270
24 ISOSPORIASIS 2 0.0256
25 CITROBACTER SEPSIS 1 0.0250
26 HERPES ZOSTER MENINGOMYELITIS 1 0.0233
27 EYE INFECTION TOXOPLASMAL 8 0.0202
28 HEPATIC ECHINOCOCCIASIS 1 0.0200
29 CRYSTALLURIA 9 0.0165
30 PLASMODIUM FALCIPARUM INFECTION 2 0.0161
31 CONGENITAL INFECTION 1 0.0161
32 ADRENAL CORTEX NECROSIS 1 0.0154
33 AIDS RELATED COMPLICATION 1 0.0154
34 CSF OLIGOCLONAL BAND PRESENT 2 0.0154
35 CRYPTITIS 2 0.0144
36 CSF SHUNT OPERATION 1 0.0139
37 ENTEROCUTANEOUS FISTULA 12 0.0136
38 ERYTHROPENIA 4 0.0132
39 CEREBRAL ASPERGILLOSIS 8 0.0130
40 KIDNEY CONGESTION 2 0.0129
41 MENINGITIS ENTEROCOCCAL 1 0.0127
42 CLOSTRIDIAL SEPSIS 3 0.0124
43 DYSDIADOCHOKINESIS 2 0.0117
44 INTERLEUKIN-2 RECEPTOR INCREASED 2 0.0117
45 NEUROPSYCHOLOGICAL SYMPTOMS 7 0.0116
46 ELECTRIC SHOCK 9 0.0105
47 SPLEEN CONGESTION 2 0.0105
48 BLEEDING TIME ABNORMAL 1 0.0097
49 FUNDOSCOPY ABNORMAL 1 0.0096
50 NEUROPSYCHIATRIC SYMPTOMS 8 0.0089
51 FAT REDISTRIBUTION 2 0.0086
52 PLEOCYTOSIS 5 0.0086
53 ACQUIRED PHIMOSIS 1 0.0084
54 HEPATIC INFECTION FUNGAL 1 0.0083
55 PRODUCT COMPOUNDING QUALITY ISSUE 3 0.0082
56 BACTERIAL TOXAEMIA 1 0.0078
57 ALLODYNIA 9 0.0077
58 GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0077
59 CEREBRAL FUNGAL INFECTION 2 0.0071
60 MYCOBACTERIAL INFECTION 12 0.0070
61 DECEREBRATE POSTURE 1 0.0068
62 GENITAL EROSION 2 0.0067
63 ANAEMIA MEGALOBLASTIC 3 0.0067
64 NEUROSYPHILIS 1 0.0066
65 NEONATAL TACHYCARDIA 1 0.0065
66 HERPES ZOSTER INFECTION NEUROLOGICAL 1 0.0063
67 CRYSTAL URINE 1 0.0063
68 ANAEMIA VITAMIN B12 DEFICIENCY 3 0.0061
69 CYTOMEGALOVIRUS SYNDROME 1 0.0061
70 BLOOD FOLATE INCREASED 1 0.0060
71 ENCEPHALITIS BRAIN STEM 1 0.0058
72 ENTEROVIRUS TEST POSITIVE 1 0.0057
73 BASOPHIL PERCENTAGE INCREASED 1 0.0057
74 CYTOMEGALOVIRUS CHORIORETINITIS 11 0.0056
75 PLASMABLASTIC LYMPHOMA 2 0.0056
76 CARDIOLIPIN ANTIBODY POSITIVE 1 0.0055
77 MONOCYTE PERCENTAGE DECREASED 1 0.0054
78 APRAXIA 8 0.0054
79 CYSTITIS VIRAL 2 0.0052
80 RETINITIS 9 0.0052
81 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
82 CD4 LYMPHOCYTES ABNORMAL 1 0.0048
83 DYSBACTERIOSIS 1 0.0047
84 GINGIVITIS ULCERATIVE 1 0.0047
85 DISSEMINATED CYTOMEGALOVIRAL INFECTION 1 0.0046
86 GINGIVAL DISCOMFORT 3 0.0045
87 NONREASSURING FOETAL HEART RATE PATTERN 1 0.0045
88 NUCHAL RIGIDITY 4 0.0044
89 INFECTION REACTIVATION 5 0.0044
90 INCISION SITE HAEMATOMA 1 0.0043
91 MENINGITIS FUNGAL 1 0.0043
92 OPTIC NEUROPATHY 9 0.0042
93 PHAEOHYPHOMYCOSIS 2 0.0042
94 ANAEMIA NEONATAL 2 0.0041
95 MICROCYTOSIS 1 0.0040
96 KAPOSI'S SARCOMA 2 0.0040
97 HYPOGONADISM 4 0.0040
98 RETROGRADE AMNESIA 2 0.0040
99 APNOEA NEONATAL 1 0.0039
100 ACQUIRED IMMUNODEFICIENCY SYNDROME 2 0.0039
101 INFECTION PARASITIC 3 0.0038
102 MYOPIA 9 0.0038
103 CEREBRAL CALCIFICATION 1 0.0037
104 CD4 LYMPHOCYTES DECREASED 8 0.0037
105 MOLLUSCUM CONTAGIOSUM 2 0.0037
106 BULBAR PALSY 1 0.0036
107 INSPIRATORY CAPACITY DECREASED 1 0.0036
108 NEWBORN PERSISTENT PULMONARY HYPERTENSION 1 0.0036
109 KLEBSIELLA SEPSIS 4 0.0035
110 NEPHROGENIC DIABETES INSIPIDUS 4 0.0035
111 HYPOURICAEMIA 1 0.0034
112 HEPATIC ARTERY THROMBOSIS 1 0.0034
113 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 2 0.0034
114 CRYSTAL NEPHROPATHY 2 0.0034
115 BONE MARROW TOXICITY 4 0.0034
116 CANDIDA SEPSIS 3 0.0033
117 HELLP SYNDROME 2 0.0033
118 DYSAESTHESIA 10 0.0033
119 PORTAL HYPERTENSION 10 0.0032
120 MONOCYTOSIS 2 0.0032
121 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 16 0.0032
122 INTRACRANIAL MASS 3 0.0032
123 EPSTEIN-BARR VIRUS TEST POSITIVE 2 0.0032
124 HEPATITIS CHOLESTATIC 19 0.0032
125 HYPERCOAGULATION 6 0.0031
126 ASPERGILLOMA 1 0.0031
127 IMMUNE RECONSTITUTION SYNDROME 4 0.0031
128 CRYPTOCOCCOSIS 5 0.0031
129 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 2 0.0030
130 DECREASED VIBRATORY SENSE 1 0.0029
131 EOSINOPHILIC FASCIITIS 1 0.0029
132 MENINGITIS CRYPTOCOCCAL 5 0.0029
133 EXANTHEM 1 0.0028
134 VASOGENIC CEREBRAL OEDEMA 2 0.0028
135 BLOOD HIV RNA INCREASED 5 0.0028
136 LIP EROSION 2 0.0027
137 ANAESTHESIA 1 0.0027
138 NEONATAL HYPOTENSION 1 0.0027
139 PHIMOSIS 2 0.0027
140 CHOROIDITIS 1 0.0027
141 LUMBAR PUNCTURE 1 0.0026
142 CALCULUS URINARY 4 0.0026
143 BRAIN DEATH 8 0.0026
144 ASEPTIC NECROSIS BONE 2 0.0026
145 ECTHYMA 1 0.0025
146 STRONGYLOIDIASIS 4 0.0025
147 ENTEROCOCCAL SEPSIS 2 0.0025
148 ORAL MUCOSA EROSION 3 0.0024
149 PERIORBITAL HAEMATOMA 2 0.0024
150 PATHOGEN RESISTANCE 22 0.0024
151 CARDIAC STRESS TEST ABNORMAL 2 0.0024
152 DENTAL DISCOMFORT 2 0.0024
153 TWIN PREGNANCY 2 0.0024
154 BRAIN ABSCESS 6 0.0024
155 COLONIC ABSCESS 2 0.0023
156 CITROBACTER INFECTION 1 0.0023
157 GLIOSIS 1 0.0023
158 IMMUNISATION 1 0.0023
159 HYPOPITUITARISM 4 0.0023
160 ENCEPHALITIS CYTOMEGALOVIRUS 1 0.0023
161 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 3 0.0023
162 POLYDIPSIA 9 0.0023
163 PRODUCT CONTAMINATION 8 0.0022
164 PLASMA CELL MYELOMA REFRACTORY 3 0.0022
165 CENTRAL NERVOUS SYSTEM LYMPHOMA 3 0.0022
166 INCISIONAL HERNIA 3 0.0022
167 TONGUE INJURY 2 0.0021
168 HEPATIC CONGESTION 2 0.0021
169 DIABETES INSIPIDUS 5 0.0021
170 CLEFT PALATE 4 0.0021
171 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
172 BONE MARROW DEPRESSION 2 0.0020
173 EVANS SYNDROME 1 0.0020
174 INTERCEPTED DRUG PRESCRIBING ERROR 1 0.0020
175 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
176 NOCARDIOSIS 5 0.0020
177 ORAL MUCOSAL ERUPTION 3 0.0020
178 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
179 HEMIPLEGIA 16 0.0019
180 HYPERLIPASAEMIA 1 0.0019
181 BRAIN MIDLINE SHIFT 1 0.0019
182 HISTOPLASMOSIS DISSEMINATED 3 0.0019
183 ENTEROCOCCAL BACTERAEMIA 2 0.0019
184 EXOMPHALOS 1 0.0019
185 INTERTRIGO 1 0.0018
186 BLOOD MAGNESIUM ABNORMAL 1 0.0018
187 CRYSTAL URINE PRESENT 1 0.0018
188 RHEUMATOID FACTOR INCREASED 2 0.0018
189 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
190 PSEUDOMEMBRANOUS COLITIS 4 0.0018
191 ENTEROBACTER INFECTION 3 0.0018
192 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
193 AMBLYOPIA 1 0.0017
194 BICUSPID AORTIC VALVE 1 0.0017
195 GRUNTING 1 0.0017
196 HEPATORENAL FAILURE 1 0.0017
197 PANCYTOPENIA 91 0.0016
198 LYMPHOPENIA 23 0.0016
199 BONE MARROW FAILURE 33 0.0016
200 XEROSIS 2 0.0016
201 CYANOSIS NEONATAL 1 0.0016
202 CHORIORETINITIS 1 0.0016
203 KLEBSIELLA TEST POSITIVE 1 0.0015
204 DELIVERY 1 0.0015
205 MACULAR FIBROSIS 1 0.0015
206 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
207 PERITONEAL HAEMORRHAGE 2 0.0014
208 MALARIA 1 0.0014
209 FANCONI SYNDROME 2 0.0014
210 LIPODYSTROPHY ACQUIRED 3 0.0014
211 ANAEMIA MACROCYTIC 3 0.0014
212 NEUROLOGICAL SYMPTOM 8 0.0014
213 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
214 PREGNANCY ON CONTRACEPTIVE 2 0.0014
215 AMINO ACID LEVEL INCREASED 1 0.0013
216 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
217 EXPOSURE TO COMMUNICABLE DISEASE 1 0.0013
218 HEPATIC NECROSIS 5 0.0013
219 HIV INFECTION 4 0.0013
220 GENITAL HERPES 2 0.0013
221 HAEMOPERITONEUM 1 0.0012
222 HERPES ZOSTER DISSEMINATED 1 0.0012
223 BLOOD CALCIUM ABNORMAL 2 0.0012
224 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
225 BRONCHOPNEUMONIA 4 0.0012
226 PSEUDOMONAL SEPSIS 2 0.0011
227 HISTOPLASMOSIS 2 0.0011
228 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
229 MUCOSAL EROSION 1 0.0011
230 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
231 VENTRICULAR ARRHYTHMIA 4 0.0011
232 EXTENSOR PLANTAR RESPONSE 1 0.0011
233 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0011
234 RASH MORBILLIFORM 3 0.0011
235 OTOTOXICITY 2 0.0011
236 LEUKOENCEPHALOPATHY 4 0.0011
237 NEPHROPATHY 10 0.0011
238 BONE CYST 1 0.0011
239 RENAL TUBULAR DISORDER 3 0.0011
240 JAUNDICE NEONATAL 2 0.0011
241 LIPOATROPHY 1 0.0011
242 DYSPNOEA AT REST 3 0.0010
243 CONVERSION DISORDER 2 0.0010
244 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
245 MASTOIDITIS 1 0.0010
246 DRUG RESISTANCE 26 0.0010
247 FACIAL PAIN 9 0.0010
248 CARDIAC ANEURYSM 1 0.0010
249 OESOPHAGEAL CANDIDIASIS 4 0.0010
250 LYMPHOCYTIC INFILTRATION 1 0.0010
251 FOETAL GROWTH RESTRICTION 6 0.0010
252 BRAIN STEM INFARCTION 1 0.0010
253 BLADDER DYSFUNCTION 1 0.0010
254 CORONAVIRUS TEST POSITIVE 1 0.0010
255 TONGUE BITING 2 0.0010
256 BREAST DISCOMFORT 1 0.0010
257 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
258 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
259 HEPATIC CYTOLYSIS 12 0.0009
260 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 1 0.0009
261 ACINETOBACTER INFECTION 1 0.0009
262 LUNG INFILTRATION 8 0.0009
263 LISTERIOSIS 1 0.0009
264 CYTOLYTIC HEPATITIS 3 0.0009
265 AORTIC DILATATION 1 0.0009
266 COMPLEX PARTIAL SEIZURES 1 0.0009
267 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
268 BK VIRUS INFECTION 3 0.0009
269 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
270 IMMUNE THROMBOCYTOPENIA 4 0.0009
271 GRANULOMA 3 0.0009
272 FOLATE DEFICIENCY 1 0.0009
273 NEUROLOGICAL DECOMPENSATION 2 0.0009
274 BLADDER OPERATION 1 0.0009
275 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
276 FLANK PAIN 8 0.0009
277 ESCHERICHIA BACTERAEMIA 2 0.0008
278 HEPATOCELLULAR INJURY 12 0.0008
279 TRANSPLANT FAILURE 2 0.0008
280 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
281 TOXIC EPIDERMAL NECROLYSIS 12 0.0008
282 HEPATIC INFECTION 1 0.0008
283 APGAR SCORE LOW 1 0.0008
284 PETECHIAE 8 0.0008
285 EXFOLIATIVE RASH 2 0.0008
286 AGRANULOCYTOSIS 14 0.0008
287 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
288 PROTEIN TOTAL INCREASED 2 0.0008
289 BLOOD POTASSIUM ABNORMAL 2 0.0007
290 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
291 BODY MASS INDEX INCREASED 1 0.0007
292 GLYCOSURIA 1 0.0007
293 MUSCLE SPASTICITY 9 0.0007
294 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
295 ALVEOLITIS 1 0.0007
296 MENINGITIS BACTERIAL 1 0.0007
297 PARAPLEGIA 2 0.0007
298 FAT TISSUE INCREASED 1 0.0007
299 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
300 CHOLESTASIS 13 0.0007
301 GENITAL PAIN 1 0.0007
302 PAPILLOEDEMA 3 0.0007
303 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
304 HYPOTONIA NEONATAL 1 0.0006
305 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
306 TORSADE DE POINTES 5 0.0006
307 STEVENS-JOHNSON SYNDROME 14 0.0006
308 JC VIRUS INFECTION 1 0.0006
309 HYPOGLYCAEMIA NEONATAL 1 0.0006
310 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
311 HEPATITIS ACUTE 4 0.0006
312 BACTERIAL SEPSIS 2 0.0006
313 POLYURIA 5 0.0006
314 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
315 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
316 CORONAVIRUS INFECTION 4 0.0006
317 COAGULOPATHY 10 0.0006
318 CEREBRAL HAEMATOMA 2 0.0006
319 KLEBSIELLA INFECTION 3 0.0006
320 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
321 FOOD AVERSION 1 0.0006
322 RASH PAPULAR 13 0.0006
323 NEURALGIA 14 0.0006
324 FANCONI SYNDROME ACQUIRED 1 0.0006
325 PURPURA 5 0.0006
326 AORTIC VALVE STENOSIS 1 0.0006
327 VIROLOGIC FAILURE 3 0.0006
328 LEUKOPENIA 27 0.0005
329 INTRACRANIAL PRESSURE INCREASED 3 0.0005
330 RETINOPATHY 2 0.0005
331 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
332 NEUTROPENIA 72 0.0005
333 BLOOD BICARBONATE DECREASED 1 0.0005
334 LIP DISORDER 1 0.0005
335 MYELOPATHY 1 0.0005
336 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
337 ENTEROCOLITIS 3 0.0005
338 HYPERTRIGLYCERIDAEMIA 3 0.0005
339 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
340 URINE ODOUR ABNORMAL 3 0.0005
341 HYPERAEMIA 1 0.0005
342 ATAXIA 6 0.0005
343 GENE MUTATION 1 0.0005
344 MYOCLONUS 6 0.0005
345 ABSCESS 8 0.0005
346 TRANSPLANT REJECTION 4 0.0005
347 CARDIAC DISCOMFORT 1 0.0005
348 LIPIDS INCREASED 1 0.0005
349 EAR HAEMORRHAGE 1 0.0005
350 ENCEPHALOPATHY 12 0.0005
351 VENTRICULAR EXTRASYSTOLES 5 0.0005
352 LUNG ABSCESS 1 0.0005
353 EAR SWELLING 1 0.0005
354 ABNORMAL SENSATION IN EYE 2 0.0005
355 EXOPHTHALMOS 1 0.0005
356 BLOOD MAGNESIUM DECREASED 4 0.0005
357 DECREASED ACTIVITY 5 0.0005
358 CARDIAC MURMUR 4 0.0005
359 BRADYPHRENIA 3 0.0005
360 CEREBELLAR SYNDROME 1 0.0005
361 PANCREATITIS 24 0.0005
362 COLONOSCOPY 1 0.0005
363 NOSOCOMIAL INFECTION 1 0.0005
364 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
365 LIVER INJURY 11 0.0004
366 CALCINOSIS 1 0.0004
367 OROPHARYNGEAL DISCOMFORT 4 0.0004
368 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
369 METASTASES TO MENINGES 1 0.0004
370 MYOCARDIAL ISCHAEMIA 5 0.0004
371 ENCEPHALITIS 3 0.0004
372 GRAND MAL CONVULSION 4 0.0004
373 LOCALISED OEDEMA 2 0.0004
374 NEPHROGENIC ANAEMIA 2 0.0004
375 ELECTROLYTE IMBALANCE 5 0.0004
376 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
377 TIBIA FRACTURE 2 0.0004
378 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
379 GRAFT VERSUS HOST DISEASE 3 0.0004
380 ENTEROCOCCAL INFECTION 2 0.0004
381 HEMIPARESIS 7 0.0004
382 FAECES SOFT 3 0.0004
383 HAEMATOLOGICAL INFECTION 1 0.0004
384 GLOMERULONEPHRITIS 1 0.0004
385 HAEMORRHAGE INTRACRANIAL 6 0.0004
386 GASTROINTESTINAL TUBE INSERTION 1 0.0004
387 DERMATITIS EXFOLIATIVE 2 0.0004
388 HYPERPARATHYROIDISM SECONDARY 1 0.0004
389 ECONOMIC PROBLEM 6 0.0004
390 MEAN CELL VOLUME INCREASED 1 0.0004
391 AORTIC ARTERIOSCLEROSIS 1 0.0004
392 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
393 THROMBOCYTOPENIA 43 0.0004
394 HEPATITIS TOXIC 1 0.0004
395 ANGIONEUROTIC OEDEMA 1 0.0004
396 BREAST PAIN 4 0.0004
397 AREFLEXIA 1 0.0004
398 ASCITES 11 0.0004
399 HYPERLACTACIDAEMIA 1 0.0004
400 BLOOD BILIRUBIN INCREASED 10 0.0004
401 HYDROCEPHALUS 2 0.0004
402 PREMATURE BABY 11 0.0004
403 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
404 CYTOMEGALOVIRUS INFECTION 6 0.0004
405 VENTRICULAR FIBRILLATION 4 0.0004
406 RASH MACULO-PAPULAR 8 0.0004
407 ATRIAL SEPTAL DEFECT 3 0.0004
408 STATUS EPILEPTICUS 4 0.0004
409 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
410 GRANULOCYTOPENIA 2 0.0004
411 PSEUDOMONAS INFECTION 3 0.0003
412 SKIN HYPERPIGMENTATION 3 0.0003
413 COLITIS 13 0.0003
414 ANHEDONIA 9 0.0003
415 EOSINOPHILIA 6 0.0003
416 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
417 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
418 LYMPHADENOPATHY 12 0.0003
419 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
420 ODYNOPHAGIA 2 0.0003
421 ATYPICAL PNEUMONIA 1 0.0003
422 POLYNEUROPATHY 4 0.0003
423 BLOOD CULTURE POSITIVE 1 0.0003
424 HEAVY MENSTRUAL BLEEDING 3 0.0003
425 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
426 MIXED LIVER INJURY 1 0.0003
427 MOUTH ULCERATION 7 0.0003
428 GANGRENE 2 0.0003
429 APHASIA 10 0.0003
430 BONE MARROW DISORDER 1 0.0003
431 CYTOPENIA 4 0.0003
432 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
433 PRE-EXISTING CONDITION IMPROVED 2 0.0003
434 ACUTE KIDNEY INJURY 49 0.0003
435 BRAIN OEDEMA 4 0.0003
436 HEPATITIS B REACTIVATION 1 0.0003
437 TRANSAMINASES INCREASED 7 0.0003
438 HEPATOTOXICITY 7 0.0003
439 HEPATITIS 8 0.0003
440 ENTERITIS 2 0.0003
441 ERUCTATION 6 0.0003
442 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
443 PHARYNGEAL SWELLING 3 0.0003
444 HEPATIC NEOPLASM 1 0.0003
445 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
446 HYPOGAMMAGLOBULINAEMIA 2 0.0003
447 ORAL CANDIDIASIS 4 0.0003
448 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
449 DRUG LEVEL INCREASED 5 0.0003
450 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
451 VISUAL ACUITY REDUCED 10 0.0003
452 LYME DISEASE 1 0.0003
453 MENINGITIS 2 0.0003
454 ANXIETY DISORDER 1 0.0003
455 TOXIC SKIN ERUPTION 3 0.0003
456 UVEITIS 4 0.0003
457 DRUG LEVEL DECREASED 3 0.0003
458 LIVER DISORDER 13 0.0003
459 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
460 MICTURITION DISORDER 1 0.0003
461 LOGORRHOEA 1 0.0003
462 BLINDNESS UNILATERAL 4 0.0003
463 NEPHROLITHIASIS 13 0.0003
464 RENAL PAIN 3 0.0003
465 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
466 DRUG ERUPTION 5 0.0003
467 MACULOPATHY 1 0.0003
468 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2 0.0003
469 BONE LESION 1 0.0003
470 VISUAL FIELD DEFECT 2 0.0003
471 BLOOD PHOSPHORUS DECREASED 1 0.0003
472 HYPOPHOSPHATAEMIA 2 0.0003
473 CEREBRAL DISORDER 2 0.0003
474 HEPATIC FAILURE 8 0.0003
475 CATHETER SITE INFECTION 1 0.0003
476 AORTIC ANEURYSM 2 0.0003
477 HAEMODYNAMIC INSTABILITY 2 0.0003
478 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
479 COMMUNICATION DISORDER 1 0.0003
480 RENAL FAILURE CHRONIC 2 0.0003
481 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
482 HAEMOLYSIS 2 0.0003
483 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
484 MENTAL STATUS CHANGES 7 0.0003
485 LOW BIRTH WEIGHT BABY 2 0.0003
486 PREMATURE DELIVERY 4 0.0003
487 MYELOSUPPRESSION 9 0.0002
488 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
489 BLOOD DISORDER 2 0.0002
490 SENSORY DISTURBANCE 4 0.0002
491 ADRENAL INSUFFICIENCY 3 0.0002
492 NO THERAPEUTIC RESPONSE 3 0.0002
493 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
494 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
495 ACUTE CORONARY SYNDROME 2 0.0002
496 TOOTH LOSS 5 0.0002
497 CONGESTIVE CARDIOMYOPATHY 1 0.0002
498 LIVE BIRTH 2 0.0002
499 HALLUCINATIONS, MIXED 1 0.0002
500 SENSATION OF FOREIGN BODY 2 0.0002
501 CANDIDA INFECTION 4 0.0002
502 HEPATIC PAIN 1 0.0002
503 HAEMATURIA 8 0.0002
504 RENAL FAILURE 31 0.0002
505 RASH GENERALISED 6 0.0002
506 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
507 MONOPLEGIA 1 0.0002
508 SEPTIC SHOCK 10 0.0002
509 DISCOMFORT 14 0.0002
510 PULMONARY CONGESTION 3 0.0002
511 HYPOXIA 8 0.0002
512 IMMUNOSUPPRESSION 2 0.0002
513 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
514 RENAL IMPAIRMENT 19 0.0002
515 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
516 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
517 BONE DENSITY DECREASED 7 0.0002
518 MYOSITIS 2 0.0002
519 MENINGITIS ASEPTIC 1 0.0002
520 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
521 END STAGE RENAL DISEASE 4 0.0002
522 ABDOMINAL HERNIA 1 0.0002
523 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
524 CHRONIC MYELOID LEUKAEMIA 1 0.0002
525 CONJUNCTIVITIS 4 0.0002
526 VOMITING 101 0.0002
527 MULTIPLE MYELOMA 1 0.0002
528 GASTRITIS EROSIVE 1 0.0002
529 PHOTOPHOBIA 4 0.0002
530 LIP SWELLING 7 0.0002
531 SUBDURAL HAEMATOMA 3 0.0002
532 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
533 HYPERTHYROIDISM 3 0.0002
534 ATELECTASIS 2 0.0002
535 RESPIRATORY FAILURE 15 0.0002
536 HEPATOMEGALY 2 0.0002
537 DISEASE PROGRESSION 24 0.0002
538 ABDOMINAL TENDERNESS 1 0.0002
539 TREATMENT NONCOMPLIANCE 11 0.0002
540 INJECTION SITE INFLAMMATION 1 0.0002
541 HYPERNATRAEMIA 1 0.0002
542 HEPATIC ENZYME ABNORMAL 1 0.0002
543 RASH MACULAR 7 0.0002
544 BRAIN INJURY 2 0.0002
545 TASTE DISORDER 4 0.0002
546 DYSLIPIDAEMIA 1 0.0002
547 DYSKINESIA 8 0.0002
548 EYELID PTOSIS 2 0.0002
549 NEUTROPHIL COUNT DECREASED 8 0.0002
550 SLUGGISHNESS 2 0.0002
551 HYPOPHAGIA 5 0.0002
552 INCREASED UPPER AIRWAY SECRETION 1 0.0002
553 MUSCULOSKELETAL STIFFNESS 17 0.0002
554 MUSCULOSKELETAL CHEST PAIN 3 0.0002
555 UNRESPONSIVE TO STIMULI 5 0.0002
556 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
557 HYPERBILIRUBINAEMIA 2 0.0002
558 FOETAL DEATH 1 0.0002
559 FAILURE TO THRIVE 1 0.0002
560 BASAL CELL CARCINOMA 3 0.0002
561 TENDERNESS 2 0.0002
562 MALABSORPTION 1 0.0002
563 APLASTIC ANAEMIA 1 0.0002
564 SEIZURE 22 0.0002
565 BLOOD LACTIC ACID INCREASED 1 0.0002
566 OFF LABEL USE 164 0.0002
567 COMPRESSION FRACTURE 1 0.0002
568 PYREXIA 64 0.0002
569 MENTAL DISORDER 8 0.0002
570 OESOPHAGITIS 2 0.0002
571 FAECALOMA 1 0.0002
572 CHOKING SENSATION 1 0.0002
573 HYPERKERATOSIS 1 0.0002
574 GASTRIC ULCER HAEMORRHAGE 1 0.0002
575 MACULAR OEDEMA 1 0.0002
576 NEPHROPATHY TOXIC 2 0.0002
577 ACUTE PULMONARY OEDEMA 1 0.0002
578 HYPONATRAEMIA 10 0.0002
579 CHROMATURIA 4 0.0002
580 EYE INFECTION 2 0.0002
581 COLECTOMY 1 0.0002
582 HYPERTONIA 1 0.0002
583 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
584 MOUTH SWELLING 1 0.0002
585 CAESAREAN SECTION 2 0.0002
586 SWELLING 16 0.0002
587 HYPOVOLAEMIA 1 0.0002
588 OSTEOPOROSIS 7 0.0002
589 LYMPHOCYTE COUNT DECREASED 3 0.0002
590 ENERGY INCREASED 1 0.0002
591 NAUSEA 134 0.0002
592 BACTERAEMIA 2 0.0002
593 CARDIO-RESPIRATORY ARREST 7 0.0002
594 RASH ERYTHEMATOUS 8 0.0002
595 HEPATITIS B 1 0.0002
596 LEUKOCYTOSIS 3 0.0002
597 RENAL FAILURE ACUTE 7 0.0002
598 MYALGIA 28 0.0002
599 HYPERGLYCAEMIA 6 0.0002
600 ACCIDENTAL OVERDOSE 6 0.0002
601 RESTLESSNESS 6 0.0002
602 LARYNGEAL OEDEMA 1 0.0002
603 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
604 EXPOSURE DURING PREGNANCY 10 0.0002
605 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
606 DRUG-INDUCED LIVER INJURY 5 0.0002
607 MUSCLE ATROPHY 2 0.0002
608 ERECTILE DYSFUNCTION 4 0.0002
609 INCOHERENT 1 0.0002
610 HERPES SIMPLEX 1 0.0002
611 HAEMORRHOIDS 3 0.0002
612 KIDNEY INFECTION 3 0.0002
613 MUCOSAL INFLAMMATION 4 0.0002
614 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
615 VIRAL INFECTION 5 0.0002
616 HOSPITALISATION 23 0.0001
617 QUALITY OF LIFE DECREASED 2 0.0001
618 THROAT TIGHTNESS 4 0.0001
619 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
620 TACHYPNOEA 2 0.0001
621 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
622 ANAEMIA 28 0.0001
623 GINGIVAL BLEEDING 2 0.0001
624 NEPHROTIC SYNDROME 1 0.0001
625 ECCHYMOSIS 1 0.0001
626 GASTROINTESTINAL DISORDER 13 0.0001
627 LYMPHOEDEMA 1 0.0001
628 HYPERTRANSAMINASAEMIA 1 0.0001
629 DERMATITIS 3 0.0001
630 HYPERKALAEMIA 5 0.0001
631 BLOOD TEST ABNORMAL 2 0.0001
632 SKIN REACTION 2 0.0001
633 FLATULENCE 8 0.0001
634 CARDIOGENIC SHOCK 2 0.0001
635 HYPOKINESIA 2 0.0001
636 LIVER FUNCTION TEST ABNORMAL 4 0.0001
637 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
638 C-REACTIVE PROTEIN INCREASED 5 0.0001
639 MAJOR DEPRESSION 1 0.0001
640 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
641 DRUG INTOLERANCE 13 0.0001
642 PANCREATITIS ACUTE 3 0.0001
643 BONE LOSS 2 0.0001
644 BLOOD POTASSIUM DECREASED 4 0.0001
645 HYPOAESTHESIA ORAL 2 0.0001
646 UNEVALUABLE EVENT 10 0.0001
647 BLOOD COUNT ABNORMAL 2 0.0001
648 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
649 VISION BLURRED 18 0.0001
650 HYPERTHERMIA 1 0.0001
651 BOWEL MOVEMENT IRREGULARITY 1 0.0001
652 LIPASE INCREASED 1 0.0001
653 PHARYNGEAL OEDEMA 2 0.0001
654 DEVICE RELATED INFECTION 2 0.0001
655 GYNAECOMASTIA 4 0.0001
656 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
657 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
658 SWOLLEN TONGUE 4 0.0001
659 AFFECTIVE DISORDER 1 0.0001
660 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
661 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
662 DRUG INTERACTION 20 0.0001
663 BLOOD ALBUMIN DECREASED 1 0.0001
664 GINGIVAL PAIN 1 0.0001
665 NIGHT SWEATS 4 0.0001
666 CONFUSIONAL STATE 20 0.0001
667 MUSCLE DISORDER 1 0.0001
668 URINARY TRACT INFECTION 21 0.0001
669 BACK DISORDER 2 0.0001
670 BLINDNESS 5 0.0001
671 HICCUPS 1 0.0001
672 MULTIPLE FRACTURES 2 0.0001
673 HYPERAESTHESIA 1 0.0001
674 LETHARGY 7 0.0001
675 MENSTRUAL DISORDER 1 0.0001
676 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
677 EOSINOPHIL COUNT INCREASED 1 0.0001
678 DEHYDRATION 16 0.0001
679 URINARY RETENTION 4 0.0001
680 FACE OEDEMA 2 0.0001
681 CHRONIC KIDNEY DISEASE 9 0.0001
682 HAEMATEMESIS 3 0.0001
683 FACIAL PARALYSIS 1 0.0001
684 ANURIA 1 0.0001
685 MULTI-ORGAN FAILURE 2 0.0001
686 HYSTERECTOMY 1 0.0001
687 MUSCULAR WEAKNESS 13 0.0001
688 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
689 RASH 49 0.0001
690 CONDITION AGGRAVATED 34 0.0001
691 GASTROINTESTINAL INFECTION 1 0.0001
692 GASTROENTERITIS VIRAL 2 0.0001
693 RASH PRURITIC 6 0.0001
694 HYPOKALAEMIA 5 0.0001
695 FEELING COLD 3 0.0001
696 HAEMOPTYSIS 3 0.0001
697 EYE SWELLING 4 0.0001
698 SWELLING FACE 7 0.0001
699 EMOTIONAL DISTRESS 13 0.0001
700 BLOOD CHOLESTEROL INCREASED 5 0.0001
701 ERYTHEMA MULTIFORME 1 0.0001
702 BLOOD CREATININE INCREASED 7 0.0001
703 BACTERIAL INFECTION 2 0.0001
704 HYPOAESTHESIA 16 0.0001
705 HEPATIC CIRRHOSIS 2 0.0001
706 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
707 DYSPHAGIA 10 0.0001
708 HAEMATOTOXICITY 1 0.0001
709 PROTEINURIA 2 0.0001
710 INSOMNIA 28 0.0001
711 HERPES ZOSTER 6 0.0001
712 DRUG PRESCRIBING ERROR 2 0.0001
713 HYPERCHOLESTEROLAEMIA 1 0.0001
714 DECREASED APPETITE 24 0.0001
715 PLATELET COUNT DECREASED 11 0.0001
716 DYSSTASIA 3 0.0001
717 DYSPHONIA 6 0.0001
718 TREMOR 17 0.0001
719 KNEE OPERATION 1 0.0001
720 TACHYCARDIA 9 0.0001
721 HOSPICE CARE 1 0.0001
722 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
723 TOXICITY TO VARIOUS AGENTS 17 0.0001
724 HEADACHE 63 0.0001
725 DIZZINESS 50 0.0001
726 ABORTION SPONTANEOUS 4 0.0001
727 FEEDING DISORDER 2 0.0001
728 EPILEPSY 3 0.0001
729 INITIAL INSOMNIA 1 0.0001
730 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
731 RIB FRACTURE 2 0.0001
732 HYPERSENSITIVITY 18 0.0001
733 LIMB DISCOMFORT 3 0.0001
734 PULMONARY HYPERTENSION 2 0.0001
735 RHABDOMYOLYSIS 4 0.0001
736 AGITATION 7 0.0001
737 SOMNOLENCE 19 0.0001
738 METABOLIC ACIDOSIS 3 0.0001
739 LIVER FUNCTION TEST INCREASED 2 0.0001
740 ASTHENIA 35 0.0001
741 LACTIC ACIDOSIS 3 0.0001
742 PRURITUS GENERALISED 2 0.0001
743 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
744 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
745 PRODUCT DOSE OMISSION 6 0.0001
746 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
747 MELAENA 2 0.0001
748 DENTAL CARIES 1 0.0001
749 FUNGAL INFECTION 3 0.0001
750 SEPSIS 10 0.0001
751 MALNUTRITION 1 0.0001
752 ORAL PAIN 2 0.0001
753 OCULAR DISCOMFORT 1 0.0001
754 BLISTER 5 0.0001
755 PARAESTHESIA 14 0.0001
756 THERAPY NON-RESPONDER 4 0.0001
757 BLOOD CALCIUM DECREASED 1 0.0001
758 MITRAL VALVE INCOMPETENCE 1 0.0001
759 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
760 PRODUCT AVAILABILITY ISSUE 2 0.0001
761 MICTURITION URGENCY 1 0.0001
762 CONVULSION 5 0.0001
763 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
764 EYELID OEDEMA 1 0.0001
765 RENAL DISORDER 4 0.0001
766 COGNITIVE DISORDER 4 0.0001
767 CHILLS 10 0.0001
768 INFECTION 12 0.0001
769 MENTAL IMPAIRMENT 2 0.0001
770 PANIC ATTACK 3 0.0001
771 CARDIOMEGALY 1 0.0001
772 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
773 PNEUMONIA ASPIRATION 2 0.0001
774 DERMATITIS ALLERGIC 1 0.0001
775 INTRAOCULAR PRESSURE INCREASED 1 0.0001
776 ABDOMINAL PAIN UPPER 16 0.0001
777 ABDOMINAL DISCOMFORT 13 0.0001
778 PLASMA CELL MYELOMA 3 0.0001
779 RESPIRATORY TRACT INFECTION 2 0.0001
780 NODULE 1 0.0001
781 GASTRITIS 2 0.0001
782 IMMUNE SYSTEM DISORDER 1 0.0001
783 DISORIENTATION 3 0.0001
784 CHEST PAIN 14 0.0001
785 FEBRILE NEUTROPENIA 5 0.0001
786 OEDEMA 4 0.0001
787 PALLOR 2 0.0001
788 DRUG TOXICITY 1 0.0001
789 HEPATIC ENZYME INCREASED 5 0.0001
790 MOOD ALTERED 2 0.0001
791 CORONARY ARTERY OCCLUSION 1 0.0001
792 DIARRHOEA 47 0.0001
793 RESPIRATORY DISTRESS 2 0.0001
794 TREATMENT FAILURE 6 0.0001
795 WEIGHT DECREASED 20 0.0001
796 MASS 1 0.0001
797 DIALYSIS 1 0.0001
798 RED BLOOD CELL COUNT DECREASED 2 0.0001
799 HYPERHIDROSIS 9 0.0001
800 EYE IRRITATION 4 0.0001
801 MYELODYSPLASTIC SYNDROME 1 0.0001
802 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
803 CONSTIPATION 15 0.0001
804 LABORATORY TEST ABNORMAL 2 0.0001
805 CARDIOMYOPATHY 1 0.0001
806 HAEMORRHAGE 7 0.0001
807 THROAT IRRITATION 3 0.0001
808 ANXIETY 19 0.0001
809 IRRITABILITY 4 0.0001
810 TINNITUS 3 0.0001
811 LYMPHOMA 1 0.0001
812 BREAST CANCER 6 0.0001
813 LUNG INFECTION 1 0.0001
814 BRAIN FOG 1 0.0001
815 HEAD INJURY 2 0.0001
816 CYSTITIS 2 0.0001
817 HYPOTHYROIDISM 2 0.0001
818 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
819 DRY MOUTH 5 0.0001
820 OSTEONECROSIS 2 0.0001
821 INFLUENZA LIKE ILLNESS 5 0.0001
822 CARDIAC ARREST 5 0.0001
823 SKIN DISORDER 2 0.0001
824 GAIT INABILITY 2 0.0001
825 PALPITATIONS 7 0.0001
826 BLOOD UREA INCREASED 1 0.0001
827 TYPE 2 DIABETES MELLITUS 2 0.0001
828 ANGER 2 0.0001
829 FLUSHING 6 0.0001
830 PAIN 36 0.0001
831 CHEST DISCOMFORT 6 0.0001
832 DYSPNOEA 33 0.0001
833 DEATH 50 0.0001
834 BALANCE DISORDER 5 0.0001
835 SPEECH DISORDER 3 0.0001
836 PRURITUS 22 0.0001
837 NEUROTOXICITY 1 0.0001
838 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
839 BRADYCARDIA 3 0.0001
840 HEAD DISCOMFORT 1 0.0001
841 BACK PAIN 13 0.0001
842 CEREBRAL HAEMORRHAGE 2 0.0001
843 DRUG INEFFECTIVE 73 0.0001
844 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
845 BLOOD GLUCOSE ABNORMAL 1 0.0001
846 MEDICATION ERROR 3 0.0001
847 HEPATIC FUNCTION ABNORMAL 2 0.0001
848 COUGH 15 0.0001
849 DYSARTHRIA 2 0.0001
850 DYSPNOEA EXERTIONAL 2 0.0001
851 HALLUCINATION 4 0.0001
852 BLOOD SODIUM DECREASED 1 0.0001
853 HYPOCALCAEMIA 1 0.0001
854 FOOT FRACTURE 1 0.0001
855 PNEUMONIA 17 0.0001
856 FEELING JITTERY 1 0.0001
857 MIGRAINE 5 0.0001
858 LOWER LIMB FRACTURE 1 0.0001
859 ABDOMINAL PAIN 12 0.0001
860 EAR PAIN 1 0.0001
861 CHOKING 1 0.0001
862 MEMORY IMPAIRMENT 7 0.0001
863 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
864 ABNORMAL BEHAVIOUR 2 0.0001
865 HAEMATOCRIT DECREASED 1 0.0001
866 HYPOTENSION 10 0.0000
867 FULL BLOOD COUNT DECREASED 1 0.0000
868 STOMATITIS 3 0.0000
869 PLEURAL EFFUSION 3 0.0000
870 VERTIGO 3 0.0000
871 BODY TEMPERATURE INCREASED 1 0.0000
872 NASOPHARYNGITIS 9 0.0000
873 VISUAL IMPAIRMENT 6 0.0000
874 DEPRESSION 11 0.0000
875 POLLAKIURIA 2 0.0000
876 MALAISE 21 0.0000
877 OSTEOARTHRITIS 2 0.0000
878 LOSS OF CONSCIOUSNESS 6 0.0000
879 IMPAIRED WORK ABILITY 1 0.0000
880 IRRITABLE BOWEL SYNDROME 1 0.0000
881 RECTAL HAEMORRHAGE 2 0.0000
882 PULMONARY OEDEMA 2 0.0000
883 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
884 SKIN DISCOLOURATION 2 0.0000
885 MUSCLE TWITCHING 1 0.0000
886 PULMONARY EMBOLISM 4 0.0000
887 URTICARIA 7 0.0000
888 DIABETIC KETOACIDOSIS 1 0.0000
889 CEREBRAL INFARCTION 1 0.0000
890 LUNG DISORDER 2 0.0000
891 BRONCHITIS 3 0.0000
892 SYNCOPE 4 0.0000
893 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
894 CARDIOVASCULAR DISORDER 1 0.0000
895 FALL 13 0.0000
896 THERAPY CESSATION 2 0.0000
897 HAEMOGLOBIN DECREASED 4 0.0000
898 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
899 INFLAMMATION 2 0.0000
900 FATIGUE 30 0.0000
901 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
902 DEAFNESS 1 0.0000
903 ARTHRITIS 3 0.0000
904 CARDIAC FAILURE CONGESTIVE 3 0.0000
905 FEAR 1 0.0000
906 JAUNDICE 1 0.0000
907 DISTURBANCE IN ATTENTION 2 0.0000
908 LIMB INJURY 1 0.0000
909 NECK PAIN 2 0.0000
910 WEIGHT INCREASED 8 0.0000
911 ALOPECIA 7 0.0000
912 OXYGEN SATURATION DECREASED 2 0.0000
913 INTENTIONAL DOSE OMISSION 1 0.0000
914 BONE PAIN 2 0.0000
915 ADVERSE DRUG REACTION 3 0.0000
916 FEELING ABNORMAL 8 0.0000
917 THERAPEUTIC RESPONSE DECREASED 2 0.0000
918 ILL-DEFINED DISORDER 2 0.0000
919 MUSCLE SPASMS 6 0.0000
920 DRUG ADMINISTRATION ERROR 1 0.0000
921 OROPHARYNGEAL PAIN 3 0.0000
922 CARDIAC DISORDER 3 0.0000
923 NERVOUS SYSTEM DISORDER 1 0.0000
924 MOVEMENT DISORDER 1 0.0000
925 ATRIAL FIBRILLATION 3 0.0000
926 AMNESIA 2 0.0000
927 CHOLELITHIASIS 1 0.0000
928 DYSPEPSIA 3 0.0000
929 IMPAIRED HEALING 1 0.0000
930 EYE DISORDER 1 0.0000
931 HEART RATE INCREASED 3 0.0000
932 CEREBROVASCULAR ACCIDENT 5 0.0000
933 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
934 GASTRIC DISORDER 1 0.0000
935 NIGHTMARE 1 0.0000
936 DELIRIUM 1 0.0000
937 ABDOMINAL DISTENSION 3 0.0000
938 MYOCARDIAL INFARCTION 5 0.0000
939 BURNING SENSATION 2 0.0000
940 MOBILITY DECREASED 2 0.0000
941 CRYING 1 0.0000
942 DYSURIA 1 0.0000
943 DYSGEUSIA 2 0.0000
944 EPISTAXIS 2 0.0000
945 PRODUCT USE ISSUE 5 0.0000
946 INTESTINAL OBSTRUCTION 1 0.0000
947 GAIT DISTURBANCE 5 0.0000
948 THROMBOSIS 2 0.0000
949 DRUG DOSE OMISSION 4 0.0000
950 SKIN EXFOLIATION 2 0.0000
951 HYPOACUSIS 1 0.0000
952 INTENTIONAL PRODUCT MISUSE 2 0.0000
953 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
954 COVID-19 4 0.0000
955 ANGIOEDEMA 1 0.0000
956 INCORRECT DOSE ADMINISTERED 5 0.0000
957 ARRHYTHMIA 1 0.0000
958 OCULAR HYPERAEMIA 1 0.0000
959 NEUROPATHY PERIPHERAL 2 0.0000
960 COMA 1 0.0000
961 MULTIPLE SCLEROSIS 1 0.0000
962 BLOOD GLUCOSE DECREASED 1 0.0000
963 INTERSTITIAL LUNG DISEASE 1 0.0000
964 AGGRESSION 1 0.0000
965 NERVOUSNESS 1 0.0000
966 ECZEMA 1 0.0000
967 DERMATITIS ATOPIC 1 0.0000
968 DEPRESSED MOOD 1 0.0000
969 OVERDOSE 4 0.0000
970 HAEMATOCHEZIA 1 0.0000
971 INFLUENZA 2 0.0000
972 EYE PAIN 1 0.0000
973 CATARACT 1 0.0000
974 OEDEMA PERIPHERAL 2 0.0000
975 FEELING HOT 1 0.0000
976 BLOOD GLUCOSE INCREASED 3 0.0000
977 DEEP VEIN THROMBOSIS 1 0.0000
978 ERYTHEMA 3 0.0000
979 ARTHRALGIA 6 0.0000
980 PAIN IN EXTREMITY 4 0.0000
981 ACNE 1 0.0000
982 DIABETES MELLITUS 1 0.0000
983 PERIPHERAL SWELLING 2 0.0000
984 CONTUSION 1 0.0000
985 PRODUCT DOSE OMISSION ISSUE 3 0.0000
986 ILLNESS 1 0.0000
987 DRY SKIN 1 0.0000
988 BLOOD PRESSURE INCREASED 1 0.0000
989 DRUG DEPENDENCE 1 0.0000
990 HYPERTENSION 1 0.0000
991 INJECTION SITE PAIN 1 0.0000